CS/CS/HB 269 – Experimental Treatments for Terminal Conditions
General Bill by Insurance & Banking Subcommittee and Health Innovation Subcommittee and Pilon (CO-SPONSORS) Harrison; Magar
Experimental Treatments for Terminal Conditions: Provides conditions for manufacturer to provide certain drugs, products, or devices to eligible patient; specifies insurance coverage requirements & exceptions; provides conditions for provision of certain services by hospital or health care facility; provides immunity from liability; provides protection from disciplinary or legal action against physician who makes certain treatment recommendations; provides that cause of action may not be asserted against manufacturer of certain drugs, products, or devices or person or entity caring for patient using such drug, product, or device under certain circumstances; provides applicability.
Effective Date: July 1, 2015
Last Event: Added to Second Reading Calendar on Wednesday, April 01, 2015 3:20 PM
Related bill: CS/SB 1052 – Florida Right to Try Act
As of 04/01/2015, this bill has been reported as “Favorable” by the Health Innovation Subcommittee, the Insurance and Banking Subcommittee, and the Health & Human Services Committee.